Amoéba S.A. (LON:0RAE)

Market Cap	55.35M +48.5%
Revenue (ttm)	585.00K -25.2%
Net Income	-6.31M
EPS	-0.12
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	484
Average Volume	5,443
Open	0.9150
Previous Close	0.9140
Day's Range	0.9150 - 0.9150
52-Week Range	0.7540 - 1.4280
Beta	0.01
RSI	43.21
Earnings Date	Apr 17, 2026

About Amoéba

Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopathogenic microorganisms using the lysed. Amoéba S.A. was incorporated in 2010 and is based in Chassieu, France.

• Industry: Miscellaneous Chemical Products
• Founded: 2010
• Employees: 20
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RAE

Financial Performance

In 2024, Amoéba's revenue was 601,600, a decrease of -9.44% compared to the previous year's 664,310. Losses were -6.59 million, -53.90% less than in 2023.

Financial numbers in EUR